Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL9J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,791
Award facts
- Contract value 100% obligated
- $37,790.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,790.59 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract carries a firm fixed price structure and is scheduled for completion by February 2, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the prime contractor's corporate office. AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, providing a comprehensive range of medications and medical supplies to support military healthcare systems and other government medical institutions.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. This prime IDC vehicle enables the company to supply an extensive catalog of pharmaceutical products, medical devices, and healthcare commodities globally to support military treatment facilities and veteran healthcare programs. The Arimidex delivery represents a routine task order fulfilling the government's requirement for this oncology medication as part of DLA's ongoing pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DR26FFL9J?
SPE2DR26FFL9J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FFL9J worth?
The government has obligated $37,791 on SPE2DR26FFL9J.
Is contract SPE2DR26FFL9J an order under another contract?
Yes. SPE2DR26FFL9J is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL9J competed?
The extent of competition for SPE2DR26FFL9J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award